Khan Lab, Department of Pathology

Western University

Created February 2008; Last updated April 01, 2014 [Z.Khan]

Home.Research Projects.Lab Members.Publications.Opportunities.News & Events.Contact.
Department of Pathology
Schulich School of Medicine & Dentistry
Western University
Publications

2014   2013   2012   2011  

2010   2009   2008   2007   2006   2005   2004   2003   2002

PDF

Todorovich SM and Khan ZA.  Elevated T-box 2 in infantile hemangioma stem cells maintains an adipogenic differentiation-competent state. Dermatoendocrinol. 5: 352-357, 2013.

 

 

McArthur K, Darling MR, and Khan ZA.  Establishing an in vitro model of salivary gland tumors.  The Cutting Edge: a publication of the American Association of Pathologists Assistants.  In press.

 

PDF

Kleiman A, Keats EC, Chan NG, and Khan ZA.  Elevated IGF2 prevents leptin induction and terminal adipocyte differentiation in hemangioma stem cells.  Exp Mol Pathol.  94: 126-36, 2013.

 

PDF

MacDonald AJ and Khan ZA. Expression of blood-brain barrier-specific antigens in non-brain derived endothelial cells despite lack of astrocyte interactions.  Br J Med Med Res 3: 29-40, 2013.

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2012

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PDF

Chen S, Chakrabarti R, Keats EC, Chen M, Chakrabarti S, Khan ZA.  Regulation of vascular endothelial growth factor expression by extra domain B segment of fibronectin in endothelial cells. Invest Ophthalmol Vis Sci.  53(13):8333-43, 2012.

 

PDF

Welten CM, Keats EC, Ang LC, and Khan ZA.  Hemangioblastoma stromal cells show committed stem cell phenotype. Can J Neurol Sci. 39, 821-827, 2012.   

 

PDF

Roach EE, Chakrabarti R. Park NI, Keats EC, Yip J, Chan NG, and Khan ZA. Intrinsic regulation of hemangioma involution by platelet-derived growth factor. Cell Death Dis. 3, e328, 2012.

 

PDF

Keats E and Khan ZA. Unique responses of stem cell-derived vascular endothelial and mesenchymal cells to high levels of glucose. PLoS ONE 7. e38752, 2012.

 

PDF

Kleiman A, Keats EC, Chan NG, and Khan ZA. Evolution of hemangioma endothelium. Exp Mol Pathol. 93:264-272, 2012.

PDF

Keats EC and Khan ZA. Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promise. Cardiovasc Diabetol. 11(1): 37, 201.

PDF

Khan ZA and Chakrabarti S. Glucose-induced cellular signalling in diabetic retinopathy. In: Visual Dysfunction in Diabetes: The Science of Patient Impairment and Health Care. Tombran-Tink J, Barnstable CJ, Gardner TW (Eds.). Humana Press. Chapter 13, pp 211-232, 2012.

 

 

2011

PDF

 

Khan ZA and Chakrabarti S. Chronic diabetic complications: endothelial cells at the frontline. In: Frontiers in Cardiovascular Drug Discovery. Choudhary MI, Rahman A (Eds.). Bentham Science Publishers Ltd, 1,121-137, 2010.

2010

PDF

Khan ZA, Chakrabarti S. Response: Inhibition of p300 and nuclear factor-kappaB by curcumin and its role in diabetic nephropathy. Nutrition. 25: 975-976, 2009.  

 

PDF

Chiu J, Khan ZA, Farhangkhoee H, and Chakrabarti S. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor κB. Nutrition. 25: 964-972, 2009.  

2009

PDF

Dudley AC, Khan ZA, Shih SC, Kang SY, Zwaans BM, Bischoff J, and Klagsbrun M. Calcification of multipotent prostate tumor endothelium. Cancer Cell. 14: 201-211, 2008.

 

PDF

Melero-Martin JM, De Obaldia ME, Kang SY, Khan ZA, Yuan L, Oettgen P, and Bischoff J. Engineering vascular networks in vivo with human postnatal progenitor cells isolated from blood and bone marrow. Circ Res. 103: 194-202, 2008.

 

PDF

Khan ZA, Boscolo E, Picard A, Psutka S, Melero-Martin JM, Bartch TC, Mulliken JB, Bischoff J. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest. 118: 2592-2599, 2008.

 

PDF

Picard A, Boscolo E, Khan ZA, Bartch T, Mulliken JB, Vazquez MP, Bischoff J. IGF-2 expression and localization in congenital versus common hemangioma. Ped Res. 63: 263-267, 2008.

2008

PDF

Khan ZA, Chakrabarti S. Cellular signaling and potential new treatment targets in diabetic retinopathy. Exp Diabetes Res. 2007/31861, 2007.

 

PDF

Xin X, Chen S, Khan ZA, Chakrabarti S. Akt activation and augmented fibronectin production in hyperhexosemia. Am J Physiol Endcrinol Metab. 293: E1036-E1044, 2007.

 

PDF

Melero-Martin JM, Khan ZA, Picard A, Wu X, Paruchuri S, Bischoff J. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood. 109: 4761-4768, 2007.

 

PDF

Chen S, Khan ZA, Karmazyn M, Chakrabarti S. Cardiomyocyte hypertrophy in diabetes: role of vasoactive factors and mitogen activated protein kinase (MAPK) activation. Diabetes Metab Res Rev. 23: 356-367, 2007.

2007

PDF

Paruchuri S, Yang JH, Rabkin-Aikawa E, Melero Martin JM, Khan ZA, Loukogeorgakis S, Schoen FJ, Bischoff J. Human pulmonary valve progenitor cells exhibit endothelial/ mesenchymal plasticity in response to VEGF-A and TGFβ2. Circ Res. 99: 861-869, 2006.

 

PDF

Kaur H, Chen S, Xin X, Chiu J, Khan ZA, Chakrabarti S. Diabetes-induced extracellular matrix protein expression is mediated by transcription co-activator p300. Diabetes. 55: 3104-3111, 2006.

 

PDF

Khan ZA, Melero-Martin JM, Wu X, Paruchuri S, Boscolo E, Mulliken J, Bischoff J. Endothelial progenitor cells from infantile hemangioma and from umbilical cord blood display unique cellular responses to endostatin. Blood. 108: 915-921, 2006.

 

PDF

Farhangkhoee H, Khan ZA, Karmazyn M, Chakrabarti S. Differential effects of curcumin on vasoactive factors in the diabetic rat heart. Nutr Metab. 3: 27-35, 2006.

PDF

Khan ZA, Chakrabarti S. Therapeutic targeting of endothelial dysfunction in chronic diabetic complications. Recent Pat. Cardiovasc. Drug Discovery. 1: 167-175, 2006.

PDF

Siddiqui I, Khan ZA, Moussa M, Garcia B, Zhong R, Chakrabarti S. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy. Transplantation. 82: 406-414, 2006.

PDF

Khan ZA, Farhangkhoee H, Chakrabarti S. Endothelins: regulators of extracellular matrix production in diabetes.  Exp Biol Med. 231: 1022-1029, 2006.

PDF

Khan ZA, Farhangkhoee H, Chakrabarti S. Towards newer molecular targets for chronic diabetic complications. Curr Vasc Pharmacol. 4: 45-57, 2006.

PDF

Farhangkhoee H, Khan ZA, Kaur H, Xin X, Chen S, Chakrabarti S. Diabetic cardiomyopathy: pathogenesis and potential treatment targets. Pharmacol Ther. 111: 384-399, 2006.

2006

PDF

Chakrabarti S, Khan ZA. Endothelins and microvascular endothelial responses in diabetes. In: Microvascular Research: Biology and Pathology. Elsevier Science, 671-676, 2005.

 

PDF

Khan ZA, Farhangkhoee H, Chan BM, Shashi U, Barbin YP, Chen S, Chakrabarti, S. ED-B fibronectin and angiogenesis – a novel mechanistic pathway. Angiogenesis. 8: 183-196, 2005.

 

PDF

Khan ZA, Farhangkhoee H, Barbin YP, Adams P, Chakrabarti S. Glucose-mediated expression of novel iron transporters in vascular endothelial cells. Free Radic Res. 39: 1203-1210, 2005.

 

PDF

Khan ZA, Cuartero J, Chan BM, Uniyal S, Barbin YP, Chakrabarti S. ED-B fibronectin in non-small cell lung carcinoma. Exp Lung Res. 31: 701-711, 2005.

PDF

Xin X, Khan ZA, Chen S, Chakrabarti S. Glucose-induced Akt1 phosphorylation mediates fibronectin synthesis in endothelial cells. Diabetologia. 48: 2428-2436, 2005.

PDF

Farhangkhoee H, Khan ZA, Barbin YP, and Chakrabarti S. Upregulation of CD36 in diabetes-induced oxidative stress and vascular endothelial cell dysfunction. Diabetologia. 48: 1401-1410, 2005.

PDF

Aleryani S, Cluette-Brown JE, Khan ZA, Hasaba H, de Hereda LL, Laposata M. Fatty acid methyl esters are detectable in the plasma and their presence correlates with liver dysfunction. Clinica Chimica Acta. 359: 141-149, 2005.

 

PDF

Fukuda G, Yoshitake N, Khan ZA, Kanazawa M, Notoya Y, Che XF, Akiyama S, Tomoda A, Chakrabarti S, Odawara M. 2-Amino-phenoxazine-3-one attenuates glucose-induced augmentation of embryonic form of myosin heavy chain, endothelin-1 and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells. Biol Pharm Bull. 28: 797-801, 2005.

 

PDF

Khan ZA, Barbin YP, Farhangkhoee H, Beier N, Scholz W, Chakrabarti S. Serum- and glucocorticoid-regulated kinase in glucose-induced oncofetal fibronectin expression. Biochem Biophys Res Commun.  329: 275-280, 2005.

 

PDF

Fukuda G, Khan ZA, Barbin YP, Farhangkhoee H, Tilton RG, Chakrabarti S. Endothelin mediated remodeling in aortas of diabetic rats. Diabetes Metab Res Rev. Rev. 21: 367-375, 2005

2005

PDF

Chen S, Khan ZA, Barbin Y, Chakrabarti S. Pro-oxidant role of heme oxygenase in mediating glucose-induced endothelial cell damage. Free Radic Res. 38: 1301-1310, 2004.

 

PDF

Xin X, Khan ZA, Chen S, Chakrabarti S. Glucose-induced and endothelin-mediated extracellular signal regulated kinase in fibronectin synthesis. Lab Invest. 84: 1451-1459, 2004.

PDF

Khan ZA, Babrin YP, Cukiernik M, Adams P, Chakrabarti S. Heme oxygenase-mediated iron accumulation in the liver. Can J Physiol Pharmacol. 82: 448-456, 2004.

PDF

Chakrabarti S, Khan ZA, Cukiernik M, Zhang W, Sima AAF. C-peptide in retinal microangiopathy in diabetes. Exp Diabesity Res. 5:1-6, 2004.

PDF

Kowluru R, Kowluru A, Chakrabarti S, Khan Z. Potential contributory role of h-ras, a small G-protein, in the development of retinopathy in diabetic rats. Diabetes. 53:775-783, 2004.

PDF

Cukiernik M, Hileeto D, Downey D, Evans T, Khan ZA, Karmazyn M, Chakrabarti S. Role of the sodium hydrogen exchanger-1 in mediating diabetes induced changes in the retina. Diabetes Metab Res Rev. 20:61-71, 2004.

 

PDF

Khan ZA, Cukiernik M, Gonder JR, and Chakrabarti S. Oncofetal fibronectin in diabetic retinopathy. Invest Ophthalmol Vis Sci. 45:287-295, 2004.

2004

PDF

Khan ZA and Chakrabarti S. Growth factors in proliferative diabetic retinopathy. Exp Diabesity Res. 4:287-301. 2003.

 

PDF

Farhangkhoee F, Khan ZA, Mukherjee S, Cukiernik M, Barbin YP, Chakrabarti S. Heme oxygenase in diabetes-induced oxidative stress in the heart. J Mol Cell Cardiol, 35:1439-1448, 2003.

 

PDF

Khan ZA, Chakrabarti S. Endothelins in chronic diabetic complications. Can J Physiol Pharmacol, 81:622-634, 2003.

PDF

Adams P, Barbin YP, Khan ZA, Chakrabarti S. Expression of ferroportin in hemochromatosis liver. Blood Cells Mol Dis, 31:256-261, 2003.

PDF

Chen S, Khan ZA, Cukiernik M, Chakrabarti S. Differential activation of NF-κB and AP-1 in target organs of diabetic complications. Am J Physiol Endocrinol Metab, 284:E1089-1097, 2003.

2003

PDF

Chakrabarti S, Khan ZA, Cukiernik M, Fukuda G, Chen S, Mukherjee S. Alteration of endothelins: a common pathogenetic mechanism in chronic diabetic complications. Int J Exp Diabetes Res, 3:217-231, 2002.

2002

PDF

Keats EC, Dominguez JM, Grant MB, and Khan ZA.  Switch from canonical to noncanonical Wnt signaling mediates high glucose-induced adipogenesis.  Stem Cells. In press PMID: 24496952

 

PDF

Kum JJY and Khan ZA.  Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis.  Pediatr Res.  75: 381-388, 2014.

 

 

 

 

 

 

 

2014